|  | Mean RSD % (HILIC +) | Mean RSD % (HILIC −) | Mean RSD % (C18 +) | Mean RSD % (C18 −) | Global Mean RSD % |
---|
PLASMA | MeOH | 30 | 24 | 27 | 19 | 25 |
MeOH:ACN | 21 | 32 | 20 | 24 | 24 |
ACN | 26 | 37 | 22 | 68 | 38 |
Hybrid-SPE/ACN | 44 | 46 | 30 | 35 | 39 |
Hybrid-SPE/MeOH | 51 | 46 | 43 | 38 | 45 |
SERUM | MeOH | 30 | 43 | 27 | 19 | 30 |
MeOH:ACN | 36 | 41 | 24 | 39 | 35 |
ACN | 36 | 80 | 43 | 74 | 58 |
Hybrid-SPE/ACN | 45 | 38 | 26 | 56 | 41 |
Hybrid-SPE/MeOH | 47 | 100 | 47 | 50 | 61 |
- The table presents the average RSD (%) computed for all potential metabolite features identified in plasma and serum through the use of five extraction techniques. The RSD for each potential metabolite feature was determined by examining the raw signal intensities from extraction replicates (n = 3). The number of features with RSD ≤ 30% (between replicates) represents high quality features that could be applied for identifying biomarkers and conducting pathway analysis in global metabolomics studies. MeOH methanol, MeOH:ACN methanol combined with acetonitrile, ACN acetonitrile, SPE solid preparation extraction, RSD relative standard deviation